We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-2.78%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$447M
AUM Growth
-$13.3M
Cap. Flow
+$5.46M
Cap. Flow %
1.22%
Top 10 Hldgs %
59.92%
Holding
43
New
3
Increased
15
Reduced
12
Closed
6

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10M
2
MDT icon
Medtronic
MDT
+$8.56M
3
ZBH icon
Zimmer Biomet
ZBH
+$8.42M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$7.32M
5
BSX icon
Boston Scientific
BSX
+$5.59M

Top Sells

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$9.52M
2
AZN icon
AstraZeneca
AZN
+$8.23M
3
MRK icon
Merck
MRK
+$7.52M
4
BDX icon
Becton Dickinson
BDX
+$6.98M
5
PDCO
Patterson Companies, Inc.
PDCO
+$4.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
26
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.62M 1.03%
80,843
– –
SAGE
27
DELISTED
Sage Therapeutics
SAGE
$3.83M 0.86%
118,476
– –
PTCT icon
28
PTC Therapeutics
PTCT
$6.47B
$3.4M 0.76%
84,864
+5,000
+6% +$175K
NVAX icon
29
Novavax
NVAX
$1.3B
$2.85M 0.64%
55,324
+17,000
+44% +$881K
VIR icon
30
Vir Biotechnology
VIR
$1.56B
$2.81M 0.63%
110,223
+30,000
+37% +$700K
RARE icon
31
Ultragenyx Pharmaceutical
RARE
$2.81B
$2.76M 0.62%
46,221
– –
UHS icon
32
Universal Health Services
UHS
$9.12B
$2.73M 0.61%
27,077
-20,390
-43% -$2.55M
RIGL icon
33
Rigel Pharmaceuticals
RIGL
$734M
$1.66M 0.37%
146,668
– –
QTRX icon
34
Quanterix
QTRX
$184M
$1.44M 0.32%
88,670
– –
SLGC
35
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.36M 0.3%
301,224
– –
ATRA icon
36
Atara Biotherapeutics
ATRA
$74.7M
$964K 0.22%
4,949
– –
EMBC icon
37
Embecta
EMBC
$204M
$133K 0.03%
+5,246
New +$151K
AZN icon
38
AstraZeneca
AZN
$255B
– –
-62,000
Closed -$8.23M
BDX icon
39
Becton Dickinson
BDX
$42.6B
– –
-26,889
Closed -$6.98M
ELAN icon
40
Elanco Animal Health
ELAN
$12.6B
– –
-364,691
Closed -$9.52M
XRAY icon
41
Dentsply Sirona
XRAY
$2.7B
– –
-55,516
Closed -$2.73M
PDCO
42
DELISTED
Patterson Companies, Inc.
PDCO
– –
-129,757
Closed -$4.2M
MRTX
43
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-11,875
Closed -$976K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2022 Portfolio in Review

As of Q2 2022, Sector Gamma AS held 43 positions worth $447M, down 2.9% from $460M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS's Q2 2022 filing shows 3 new, 15 increased, 12 reduced and 6 closed positions. Its largest new stake was Seagen Inc. Common Stock: 50,795 shares worth $8.99M. The largest sale was Elanco Animal Health, an estimated $9.52M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q2 2022 buy was Seagen Inc. Common Stock: 50,795 shares worth $8.99M.
  • Sector Gamma AS added most to Gilead Sciences in Q2 2022, an estimated $10M increase.
  • Sector Gamma AS's biggest Q2 2022 reduction was Merck, cutting an estimated $7.52M.
  • Sector Gamma AS fully exited Elanco Animal Health in Q2 2022, selling an estimated $9.52M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $447M portfolio in Q2 2022.
  • Sector Gamma AS opened 3 new positions and closed 6 in Q2 2022.
  • Sector Gamma AS's portfolio value fell 2.9% quarter-over-quarter to $447M.

Based on Sector Gamma AS's 13F filing for Q2 2022, filed 5 Aug 2022.